Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

31.59
Delayed Data
As of 4:02pm ET
 -0.04 / -0.13%
Today’s Change
28.25
Today|||52-Week Range
37.39
-2.14%
Year-to-Date
Robust Pipeline Supports 5.5% Dividend Yield
10:34am / GuruFocus News - Paid Partner Content
Forget Pfizer: Here Are 3 Better Dividend Stocks
Dec 02 / MotleyFool.com - Paid Partner Content
2 Stocks That Could Soar Under a Donald Trump Presidency
9:48am / MotleyFool.com - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
Pfizer (PFE) Presents Favorable Data on Leukemia Candidate
9:43am / Zacks.com - Paid Partner Content
Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug
Dec 02 / Zacks.com - Paid Partner Content
Does Pfizer Pass Warren Buffetts Test?
Dec 04 / MotleyFool.com - Paid Partner Content
Why Exelixis Was a Top Stock in 2016 So Far
Dec 02 / MotleyFool.com - Paid Partner Content
Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions
Dec 03 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close31.63
Today’s open31.74
Day’s range31.39 - 31.77
Volume19,300,238
Average volume (3 months)23,325,510
Market cap$191.9B
Dividend yield3.80%
Data as of 4:02pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+9.95%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-1.52%
P/E ratio31.6
Price/Sales4.13
Price/Book3.02

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.88-1.44%
NVSNovartis+0.80+1.17%
SNYSanofi+0.89+2.22%
ABBVAbbVie+1.43+2.41%
Data as of 4:03pm ET, 12/05/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.50
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs